There are two main types of lung cancer: small cell and non-small cell. According to the American Cancer Society, non-small ...

New research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that anatomic lung resections, such as lobectomy and segmentectomy, are associated with improved long-term ...

Small Cell Lung Cancer Pipeline Insight 2025' report provides comprehensive global coverage of pipeline NSCLC therapies in ...

New research highlights the promise of a novel stem cell treatment strategy for leptomeningeal brain metastasis (LBM), a ...

Nov. 6, 2024 — Exhaled breath contains chemical clues to what's going on inside the body, including diseases like ... New, Rare Type of Small Cell Lung Cancer Identified Sep. 11, 2024 ...

Nov. 6, 2024 — Exhaled breath contains chemical clues to what's going on inside the body, including diseases like ... targeted treatment for non-small cell lung cancer fails to work for some ...

AstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for the treatment of lung cancer patients across ...

Chavez, MD, discusses how comprehensive genomic profiling may impact the treatment and clinical management of patients with small cell lung cancer.

Osimertinib, also known as Tagrisso and made by AstraZeneca, can help stop cancer from returning after surgery ...

A phase 2a trial of IMM-1-104 plus chemotherapy demonstrated efficacy and tolerability in first- and second-line pancreatic ...

Personalis, Inc. (Nasdaq: PSNL), in collaboration with Professor Charles Swanton and his colleagues at London’s Francis Crick Institute and University ...

Personalis (PSNL) published new results from their TRACERx lung cancer study in Nature Medicine. In this study, co-authors Black and Bartha et ...